1. Home
  2. EMBC vs MRVI Comparison

EMBC vs MRVI Comparison

Compare EMBC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.06

Market Cap

524.1M

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$4.09

Market Cap

559.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBC
MRVI
Founded
1924
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
524.1M
559.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
EMBC
MRVI
Price
$3.06
$4.09
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$18.50
$4.13
AVG Volume (30 Days)
3.0M
2.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
6.88%
N/A
EPS Growth
20.90
14.29
EPS
0.67
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$1.17
$12.54
Revenue Next Year
N/A
$7.87
P/E Ratio
$4.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$1.99
52 Week High
$15.55
$5.00

Technical Indicators

Market Signals
Indicator
EMBC
MRVI
Relative Strength Index (RSI) 14.26 55.18
Support Level N/A $3.27
Resistance Level $9.51 $5.00
Average True Range (ATR) 0.38 0.25
MACD -0.32 -0.00
Stochastic Oscillator 0.97 40.66

Price Performance

Historical Comparison
EMBC
MRVI

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: